Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 16 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (6)
P 1 (1)
P 4 (1)

Trial Status

Recruiting6
Completed4
Not Yet Recruiting2
Unknown2
Withdrawn1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06274411Not ApplicableRecruitingPrimary

Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention

NCT07193719Phase 1Recruiting

Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children

NCT06872021Not ApplicableRecruitingPrimary

Early Intra-aortic Balloon Pump Use After Venoarterial Extracorporeal Membrane Oxygenation

NCT04496362Phase 4Active Not RecruitingPrimary

Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study

NCT07368868Completed

Effect of Initiation of Veno-venous ECMO on Urine Output and Acute Kidney Injury

NCT07039513Not Yet RecruitingPrimary

EVOLUTION OF D-DIMER AS A MARKER OF BLEEDING RISK ON ECMO

NCT07138599Not ApplicableCompletedPrimary

Virtual Reality Training for ECMO Circuit Checks

NCT06560164Not ApplicableRecruiting

Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO

NCT06676085Not ApplicableRecruitingPrimary

A Novel Strategy of ECMO Management Using Nafamostat for Regional Combined With Low Intensity Systematic Anticoagulation

NCT06662084RecruitingPrimary

The ECMOCYP (cytochromes P450 Activity) Study

NCT06654388CompletedPrimary

To Construct a Prognosis Prediction Model for ECMO Patients Based on Machine Learning Algorithms

NCT06210542Not Yet RecruitingPrimary

Precise Treatment of Ceftazidime-Avibactam in Patients With CRO Infections Under the Guidance of TDM and PPK Model

NCT04478136WithdrawnPrimary

Can Blood Panels Provide Early Warning of Bleeding in Patients on ECMO?

NCT04990752UnknownPrimary

Effects of Ulinastatin on Inflammatory Response During ECMO Support

NCT03981393Completed

Cardinality Matching Study of Early v.s. Delayed VV ECMO in Severe Respiratory Failure

NCT04340414Not ApplicableUnknown

Safety and Effectiveness of Low-flow ECMO Driving by CVVH Machine in Severe NCP

Showing all 16 trials

Research Network

Activity Timeline